For its pharmaceutical use, the global soft tissue repair market has been valued at around USD 11.15 billion in 2015 and is expected to reach approximately USD 17.12 billion by 2021, growing at a CAGR of around 7.5% between 2016 and 2021.
For its cosmeceutical use, the market was valued at USD 42.24 billion in 2016 and is expected to reach a value of USD 68.72 billion by 2022, witnessing a CAGR of 8.52% during the forecast period, 2017-2022.
Patent Application: SIB BI5072R, “Tetraselmis suecica green microalga crude extract and its uses”; 12/07/2017
The marine green microalga Tetraselmis suecica contains high levels of carotenoids such as the xanthophylls lutein, violaxanthin, neoxanthin, antheraxanthin and loroxanthin esters. Extractof this species have a strong antioxidant and repairing activity in human cell lines and also reduces prostaglandin E2 (PGE2) levels and has tissue repairing effects on reconstructed human epidermal tissue cells (EpiDermTM). Available data thus indicate an interesting tissue repairing activity for both the cosmeceutical and the pharmaceutical markets.